WINTON GROUP Ltd

Position in EDIT — Editas Medicine, Inc.

CIK 1612063 LONDON, X0

Position in EDIT

as of Mar 31, 2026 · filed May 12, 2026 Compact

Position Value

$108,186

-$42,788 QoQ

Shares Held

43,800

+110.3% QoQ

Ownership

0.045%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

11 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

WINTON GROUP Ltd holds $82,877,062 across 71 Biotechnology names. EDIT ranks #63 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp	173,032	$16,285,771
2	REGN	Regeneron Pharmaceuticals, Inc.	14,778	$11,418,073
3	IONS	Ionis Pharmaceuticals Inc	106,532	$7,999,487
4	BBIO	BridgeBio Pharma, Inc.	47,925	$3,558,910
5	ARWR	Arrowhead Pharmaceuticals, Inc.	55,080	$3,453,516
6	VIR	Vir Biotechnology, Inc.	367,883	$3,296,231
7	FTRE	Fortrea Holdings Inc.	307,096	$2,892,844
8	APLS	Apellis Pharmaceuticals, Inc.	69,291	$2,787,576

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$108,186	43,800	+110.3%	Shares	Sole	2026-05-12
2023-03-31	$150,974	20,824	-1.4%	Shares	Sole	2023-05-12
2022-12-31	$187,423	21,130	+6.0%	Shares	Sole	2023-02-14
2022-09-30	$243,930	19,929	-11.0%	Shares	Sole	2022-11-10
2022-06-30	$265,015	22,402	+27.0%	Shares	Sole	2022-08-10
2022-03-31	$335,436	17,636	+23.1%	Shares	Sole	2022-05-11
2021-12-31	$380,434	14,329	+85.5%	Shares	Sole	2022-02-10
2020-12-31	$541,459	7,723	-83.0%	Shares	Sole	2021-02-12
2020-09-30	$1,273,475	45,384	+297.3%	Shares	Sole	2020-10-30
2020-06-30	$337,862	11,422	-55.4%	Shares	Sole	2020-08-05
2020-03-31	$507,350	25,585	—	Shares	Sole	2020-05-11
No filing history on record for this holder in this stock.